APSR2026-1052

 
Late-Breaking
Submitted
Poster Presentation
 
AP14-018
P37
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1245594-46904-提出用_433759.pdf
Format: PDF Only
08. Lung Cancer
2

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Hiroaki Ota * Iizuka Hospital Department of Respiratory Medicine Iizuka Japan
Kazunori Tobino - Iizuka Hospital Department of Respiratory Medicine Iizuka Japan
 
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Hiroaki
Ota
realflvna@gmail.com
+819048945345
31-40
Japan
Original Research
Cryobiopsy versus forceps biopsy during medical thoracoscopy for lung cancer pleural lesions: specimen adequacy for molecular testing
Maximum 25 words
Abstract Content
For pleural lesions in lung cancer, obtaining specimens with sufficient tumor cellularity for programmed death-ligand 1 (PD-L1) and molecular testing is increasingly important. This exploratory study compared cryobiopsy during medical thoracoscopy under local anesthesia with conventional forceps biopsy for specimen adequacy and safety.
We retrospectively reviewed patients who underwent medical thoracoscopy under local anesthesia for lung cancer pleural lesions at our institution from 2018 to 2026. Collected data included patient characteristics, biopsy method, number of biopsies, procedure time, tumor cell proportion, tumor cell count, PD-L1 submission, molecular testing submission and success, complications, and pleural fluid findings. The primary endpoint was achievement of both tumor cell proportion 30% or higher and tumor cell count 600 cells or higher. Secondary endpoints included each criterion separately, procedure time, and safety.
After excluding one patient who underwent both methods, 21 patients in the forceps group and 17 in the cryobiopsy group were analyzed. The primary endpoint was achieved in 6/21 patients (29%) in the forceps group and 11/17 (65%) in the cryobiopsy group (Fisher's exact test, p=0.048). Tumor cell proportion 30% or higher was achieved in 7/21 (33%) and 13/17 (77%), respectively (p=0.011). Tumor cell count 600 cells or higher was achieved in 16/21 (76%) and 14/17 (94%), respectively (p=0.71). Procedure time was similar (21.4 minutes [range, 13-56] versus 25.3 minutes [range, 12-60]), as were complication rates (9.5% versus 11.8%).
Cryobiopsy during medical thoracoscopy under local anesthesia may improve specimen adequacy for molecular testing in lung cancer pleural lesions without substantially compromising safety.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
medical thoracoscopy, cryobiopsy, lung cancer
maximum 3 keywords and no abbreviations, separated by commas
 
265